Cargando…
Is immunosuppression status a risk factor for noninvasive ventilation failure in patients with acute hypoxemic respiratory failure? A post hoc matched analysis
BACKGROUND: Recent European/American guidelines recommend noninvasive ventilation (NIV) as a first-line therapy to manage acute hypoxemic respiratory failure in immunocompromised patients. By contrast, NIV may have deleterious effects in nonimmunocompromised patients and experts have been unable to...
Autores principales: | Coudroy, Rémi, Pham, Tài, Boissier, Florence, Robert, René, Frat, Jean-Pierre, Thille, Arnaud W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692798/ https://www.ncbi.nlm.nih.gov/pubmed/31414246 http://dx.doi.org/10.1186/s13613-019-0566-z |
Ejemplares similares
-
Noninvasive Oxygenation in Patients with Acute Respiratory Failure: Current Perspectives
por: Frat, Jean-Pierre, et al.
Publicado: (2022) -
High-flow nasal cannula oxygen therapy versus noninvasive ventilation in immunocompromised patients with acute respiratory failure: an observational cohort study
por: Coudroy, Rémi, et al.
Publicado: (2016) -
Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors
por: Thille, Arnaud W, et al.
Publicado: (2013) -
High-flow nasal cannula oxygen therapy in acute hypoxemic respiratory failure and COVID-19-related respiratory failure
por: Frat, Jean-Pierre, et al.
Publicado: (2022) -
High-flow nasal cannula oxygen therapy versus noninvasive ventilation versus in immunocompromised patients with acute respiratory failure
por: Coudroy, R, et al.
Publicado: (2015)